Featured Research

from universities, journals, and other organizations

Lymphomas Need Distinct Care

Date:
December 24, 2004
Source:
University Of Southern California
Summary:
When it comes to treating HIV-positive patients with blood cancers, not all lymphomas are created equal, according to hematologists from USC.

When it comes to treating HIV-positive patients with blood cancers, not all lymphomas are created equal, according to hematologists from USC.

Although physicians have treated all types of lymphomas in HIV/AIDS patients with the same drug regimens, researchers from the USC/Norris Comprehensive Cancer Center and Hospital said the drugs are significantly more effective in patients with diffuse large-cell lymphoma, or DLCL, than in patients with small non-cleaved, or SNC, lymphoma.

The findings, reported at the 46th annual meeting of the American Society of Hematology Dec. 6, suggest that researchers rethink the practice of using the same uniform treatment for everyone with AIDS-related lymphomas.

“Lymphoma is not one disease, but rather represents a group of over 30 different entities,” said Alexandra M. Levine, Distinguished Professor of Medicine, chief of hematology in the Keck School of Medicine of USC and medical director of the USC/Norris Cancer Hospital.

“Even lymphomas that were thought to be quite uniform and homogeneous are now recognized as being made up of different variations or sub-types. It will be important for scientists and physicians to recognize these various types, since optimal therapy in the future will probably differ for these sub-types of disease,” Levine said.

The USC hematologists reviewed records of more than 350 patients with the AIDS-related lymphomas treated at USC/Norris between 1982 and early 2004; 135 patients had SNC and 227 patients had DLCL.

The researchers looked at cases occurring before the advent of highly active antiretroviral therapy, or HAART, in 1996, as well as after the introduction of the successful anti-HIV therapy. They saw 117 SNC cases and 143 DLCL cases before HAART, and 18 SNC and 84 DLCL cases after HAART.

Throughout the period, all lymphoma patients were treated for their cancers with one of two equivalent, common chemotherapy combinations: cyclophosphamide, vincristine, adriamycin and prednisone; or methotrexate, bleomycin, adriamycin, cyclophosphamide, vincristine and dexamethasone.

USC/Norris researchers found that before HAART, overall survival of SNC and DLCL patients was about the same – about six or seven months. But after HAART, patients with DLCL began living significantly longer.

DLCL patients’ average survival time after HAART’s 1996 introduction was 38 months – more than six times as long as SNC patients’ average survival time of 5.6 months.

The researchers also found that SNC patients were more likely than DLCL patients to have secondary cancer in their bone marrow, liver and kidneys.

“Prior to the availability of effective treatment against HIV, patients with AIDS-related lymphoma often died of serious infections before they could receive adequate or optimal chemotherapy; the survival of these patients was quite short, in the range of only six months,” Levine said.

“Importantly, effective anti-HIV treatment has now allowed these patients to receive chemotherapy and to benefit from it.

“However, our study has shown that not all types of lymphoma are the same, and different treatments will be required to achieve optimal results in these individuals,” Levine said.

“We expect that our study will eventually serve to change the way in which patients with AIDS-related Burkitt lymphoma are treated.”


Story Source:

The above story is based on materials provided by University Of Southern California. Note: Materials may be edited for content and length.


Cite This Page:

University Of Southern California. "Lymphomas Need Distinct Care." ScienceDaily. ScienceDaily, 24 December 2004. <www.sciencedaily.com/releases/2004/12/041219141837.htm>.
University Of Southern California. (2004, December 24). Lymphomas Need Distinct Care. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2004/12/041219141837.htm
University Of Southern California. "Lymphomas Need Distinct Care." ScienceDaily. www.sciencedaily.com/releases/2004/12/041219141837.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins